Pharmaceutical Technology11h
Omalizumab biosimilar by Mabpharm for Chronic Urticaria Or Hives: Likelihood of Approval
Omalizumab biosimilar is under clinical development by Mabpharm and currently in Phase III for Chronic Urticaria Or Hives. According ...
tennisuptodate8h
Tournament Centre Adelaide International 2025: Schedule, results, Prize Money and TV Guide
The Adelaide International will take place from January 6-11, 2025 and TennisUpToDate is the one place to follow the action ...